Arcalyst

Active Ingredient(s): Rilonacept
FDA Approved: * February 27, 2008
Pharm Company: * REGENERON PHARMACEUTICALS
Category: Anti-Inflammatory

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Arcalyst Overview

Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis.[1][2][3] Rilonacept is an interleukin 1 inhibitor.[4] Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellula...

Read more Arcalyst Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rilonacept

Recent Arcalyst Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rilonacept
  • Vial: 220mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Arcalyst: (1 result)

Sorted by National Drug Code
  • 61755-001 Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Regeneron Pharmaceuticals, Inc.

Other drugs which contain Rilonacept or a similar ingredient: (1 result)